
LSX RNA Leaders, September 10-11, 2025, Boston
July 14, 2025/by Ayal Ronen
Asia Bio Partnering Forum, September 9-10, 2025, Singapore
July 11, 2025/by Ayal Ronen
DOGE Loses Control Over Federal Grants — A Turning Point in U.S. Grant-Making
June 30, 2025/by Ayal Ronen
Analyzing the FY26 White House Budget-in-Brief Impact on Life Science R&D Companies
June 3, 2025/by Ayal Ronen
RESI, June 16, 2025, Boston
May 20, 2025/by Ayal Ronen
HLTH Europe June 16-19, 2025, Amsterdam
May 20, 2025/by Ayal Ronen
Sachs Associates European Biopharma Obesity Innovation Forum, June 11-12, 2025, Leipzig
May 19, 2025/by Ayal Ronen
Informa Antibody Engineering & Therapeutics, June 10-12, 2025, Basel
May 18, 2025/by Ayal Ronen
The SBIR/STTR Reauthorization Act of 2025: Investing in Small Business Innovation and Entrepreneurship
May 7, 2025/by Ayal Ronen
Sentiment vs. Funding Facts: A Closer Look at Non-Dilutive Funding Realities and Public Perception
April 15, 2025/by Ayal Ronen
ChinaBio, April 23-24, 2025, Shanghai
April 6, 2025/by Ayal Ronen
FreeMind Group and Jameson & Co Forge Powerful Alliance to Elevate Non-Dilutive Funding Services for Life Sciences
March 30, 2025/by Ayal RonenSearch
Recent Posts
- LSX Investival Showcase, November 17, 2025, LondonSeptember 11, 2025 - 10:04 am
- BioEurope, November 3-5, 2025, ViennaSeptember 9, 2025 - 10:04 am
- BioFuture, October 13-15, 2025, New YorkSeptember 4, 2025 - 11:36 am
- Sachs Associates Biotech in Europe Forum, October 8-9, 2025, BaselSeptember 2, 2025 - 12:47 pm
- Sachs Associates HealthTech Investment Forum, October 7, 2025, BaselSeptember 2, 2025 - 12:47 pm